These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 1280979

  • 1. Selenite-induced inhibition of colony formation by buthionine sulfoximine-sensitive and resistant cell lines.
    Caffrey PB, Frenkel GD.
    Biol Trace Elem Res; 1992 Nov; 35(2):129-36. PubMed ID: 1280979
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of cell colony formation by selenite: involvement of glutathione.
    Caffrey PB, Frenkel GD.
    Mol Pharmacol; 1991 Mar; 39(3):281-4. PubMed ID: 1826039
    [Abstract] [Full Text] [Related]

  • 3. Effect of buthionine sulfoximine on PtII and PtIV drug accumulation and the formation of glutathione conjugates in human ovarian-carcinoma cell lines.
    Mistry P, Loh SY, Kelland LR, Harrap KR.
    Int J Cancer; 1993 Nov 11; 55(5):848-56. PubMed ID: 8244583
    [Abstract] [Full Text] [Related]

  • 4. Buthionine sulfoximine spares intracellular glutamate: a possible mechanism for cell growth stimulation.
    Kang YJ.
    Cell Mol Biol Res; 1993 Nov 11; 39(7):675-84. PubMed ID: 8055000
    [Abstract] [Full Text] [Related]

  • 5. Buthionine sulfoximine enhances glutathione-but attenuates glutamate-stimulated cell proliferation.
    Kang YJ.
    Cell Mol Biol Res; 1995 Nov 11; 41(2):131-6. PubMed ID: 8581064
    [Abstract] [Full Text] [Related]

  • 6. Exogenous glutathione attenuates the antiproliferative effect of buthionine sulfoximine.
    Kang YJ.
    Toxicology; 1994 Mar 11; 88(1-3):177-89. PubMed ID: 8160199
    [Abstract] [Full Text] [Related]

  • 7. Overcoming tumor necrosis factor-alpha resistance of human renal and ovarian carcinoma cells by combination treatment with buthionine sulfoximine and tumor necrosis factor-alpha. Role of tumor necrosis factor-alpha mRNA down-regulation in tumor cell sensitization.
    Mizutani Y, Yoshida O.
    Cancer; 1994 Feb 01; 73(3):730-7. PubMed ID: 8299097
    [Abstract] [Full Text] [Related]

  • 8. [Increasing chemosensitivity to cisplatin by glutathione depletion with buthionine sulfoximine. In vitro and in vivo studies with a human squamous cell cancer line].
    Bier H.
    Laryngorhinootologie; 1990 Jan 01; 69(1):16-20. PubMed ID: 2310456
    [Abstract] [Full Text] [Related]

  • 9. Combined effects of buthionine sulfoximine and cepharanthine on cytotoxic activity of doxorubicin to multidrug-resistant cells.
    Kisara S, Furusawa S, Murata R, Ogata M, Hikichi N, Takayanagi Y, Sasaki K.
    Oncol Res; 1995 Jan 01; 7(3-4):191-200. PubMed ID: 8555653
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Glutathione depletion by L-buthionine sulfoximine antagonizes taxol cytotoxicity.
    Liebmann JE, Hahn SM, Cook JA, Lipschultz C, Mitchell JB, Kaufman DC.
    Cancer Res; 1993 May 01; 53(9):2066-70. PubMed ID: 8097674
    [Abstract] [Full Text] [Related]

  • 12. Mitomycin C sensitivity in human bladder cancer cells: possible role of glutathione and glutathione transferase in resistance.
    Xu BH, Gupta V, Singh SV.
    Arch Biochem Biophys; 1994 Jan 01; 308(1):164-70. PubMed ID: 8311448
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Buthionine sulfoximine induced growth inhibition in human lung carcinoma cells does not correlate with glutathione depletion.
    Kang YJ, Emery D, Enger MD.
    Cell Biol Toxicol; 1991 Jul 01; 7(3):249-61. PubMed ID: 1933516
    [Abstract] [Full Text] [Related]

  • 15. Effect of buthionine sulfoximine, an inhibitor of glutathione biosynthesis, on the selenium-induced lethality in mice.
    Ishikawa M, Takayanagi G, Sasaki K.
    Jpn J Pharmacol; 1988 Oct 01; 48(2):283-6. PubMed ID: 3210451
    [Abstract] [Full Text] [Related]

  • 16. Buthionine sulphoximine-mediated sensitisation of etoposide-resistant human breast cancer MCF7 cells overexpressing the multidrug resistance-associated protein involves increased drug accumulation.
    Schneider E, Yamazaki H, Sinha BK, Cowan KH.
    Br J Cancer; 1995 Apr 01; 71(4):738-43. PubMed ID: 7710938
    [Abstract] [Full Text] [Related]

  • 17. Selective modulation of glutathione levels in human normal versus tumor cells and subsequent differential response to chemotherapy drugs.
    Russo A, DeGraff W, Friedman N, Mitchell JB.
    Cancer Res; 1986 Jun 01; 46(6):2845-8. PubMed ID: 2421885
    [Abstract] [Full Text] [Related]

  • 18. Evidence for the involvement of sulfhydryl compounds in the inhibition of cellular DNA synthesis by selenite.
    Frenkel GD, Falvey D.
    Mol Pharmacol; 1988 Oct 01; 34(4):573-7. PubMed ID: 3173336
    [Abstract] [Full Text] [Related]

  • 19. Sensitivity of human melanoma cells to L-dopa and DL-buthionine (S,R)-sulfoximine.
    Kable EP, Favier D, Parsons PG.
    Cancer Res; 1989 May 01; 49(9):2327-31. PubMed ID: 2706620
    [Abstract] [Full Text] [Related]

  • 20. Differential sensitivities of murine melanocytes and melanoma cells to buthionine sulfoximine and anticancer drugs.
    Thrall BD, Raha GA, Springer DL, Meadows GG.
    Pigment Cell Res; 1991 Dec 01; 4(5-6):234-9. PubMed ID: 1823927
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.